18 Live Notices for Omalizumab Tenders
Showing 1 to 18
Delivery Of Medicinal Products To Drug Programs For Patients Of The Specialist Hospital In Zabrze Sp. Z O.O.; Case Number Dzp/19 Pn/2025
01 Aug 2025
05 Sep 2025Object: Electronic Auction - Electronic Auction, With Price Registration System, For The Acquisition Of Alpha 1 Anthripsin, Benralizumab, Lacosamide, Nintedanib, Pirfenidone, Tocilizumab, Tiotropio, Omalizumab And Enzalutamide, According To The Specifications Contained In The Notice And Their Attachments.
Object: Electronic Auction - Price Registration For Future And Eventual Acquisitions Of Medicines To Attend To Patients In The Municipality Of Divinópolis/Mg, Covered By Judicial Warrants, According To Specifications Of Annex I Of This Notice.
Object: Electronic Auction - Price Registration Formation For The Eventual Supply Of Medicines To Meet The Needs Of The Units Linked To The State Department Of Health Of Pernambuco Met By The Pernambuco State Pharmaceutical Assistance Directorate, According To The Conditions, Specifications, Quantities And Requirements Contained In The Term Of Reference.
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V To Medicinal Products With The Active Ingredient Omalizumab (Atccode: R03Dx05).
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V To Medicinal Products With The Active Ingredient Omalizumab (Atccode: R03Dx05).
Delivery Of Medicinal Products Settled From The Package Of Magic Programs And Chemotherapy Specified In 7 Packages.
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Omalizumab (Atc Code: R03Dx05).
Pharmaceutical Discount Contracts In Accordance With Section 130A (8) Sgb V As Part Of Open House Procedures
Drug Supply - The Active Substance Omalizumab - Atc R03Dx05
Open House Pharmaceutical Discounts On The Active Ingredient Omalizumab, Atc R03Dx05
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (Atc Code: R03Dx05).
Abschluss Eines Nicht Exklusiven Rabattvertrages Nach § 130A Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Omalizumab (Atc-Code: R03Dx05).
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Para. 8 Sgb V For The Active Ingredient Omalizumab
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab, Atc R03Dx05 (Obo) For The Period 01.08.2024 - 31.07.2025 (Plus Extension Option 1X12 Months)
Open House Biologics Discount Agreements 2024-03 - Omalizumab
Open House Biologics Discount Agreements 2024-03 - Omalizumab
Inj. Omalizumab 150Mg In Vial
Tenders by Country